Back to Search Start Over

supplementary tables from Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma

Authors :
Judith V.M.G. Bovée
Karoly Szuhai
Geert J.L.H. van Leenders
Ferry A.L.M. Eskens
Hans Gelderblom
Stefan Sleijfer
David G.P. van IJzendoorn
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Supplementary table 1 Primers sequences used for Real-Time qPCR. Supplementary table 2 ShRNA used for inhibition of the receptors, for each receptor the most effective shRNA was selected as tested with Real-Time qPCR. Supplementary table 3 Sequence of the primers used for ChIP-qPCR.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....14386f00029181604781520ebdd88e28